Answers are grounded in this paper and cite their sources.
Clinical review reveals evolving disease-modifying therapies in patients with multiple sclerosis, highlighting emerging insights into underlying disease mechanisms.
Multiple sclerosis affects more than 2 million people worldwide and is currently incurable. A number of interventions to modify the course of multiple sclerosis have been developed that offer new insight into disease mechanisms.
No takes yet. Share an insight, caveat, or question.
Reich et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: